Cargando…

In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model

The Scottish Cancer Therapy Network (SCTN) was created against a background of rising concerns about perceived variation in the quality of care available to patients with cancer. SCTN has established itself as a major organization with the necessary recognition and infrastructure to provide leadersh...

Descripción completa

Detalles Bibliográficos
Autores principales: Stroner, P L, Brewster, D H, Dewar, J A, Eremin, O, Gould, A, Howard, G C, Kaye, S B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362781/
https://www.ncbi.nlm.nih.gov/pubmed/10206271
http://dx.doi.org/10.1038/sj.bjc.6690262
_version_ 1782153539524493312
author Stroner, P L
Brewster, D H
Dewar, J A
Eremin, O
Gould, A
Howard, G C
Kaye, S B
author_facet Stroner, P L
Brewster, D H
Dewar, J A
Eremin, O
Gould, A
Howard, G C
Kaye, S B
author_sort Stroner, P L
collection PubMed
description The Scottish Cancer Therapy Network (SCTN) was created against a background of rising concerns about perceived variation in the quality of care available to patients with cancer. SCTN has established itself as a major organization with the necessary recognition and infrastructure to provide leadership, support and impetus in the field of clinical guidelines, clinical audit and clinical trials of cancer therapy in Scotland. Since being formed in 1993, SCTN has been instrumental in the development of three evidence-based, clinical guidelines and in the completion of detailed, national, retrospective audits of the treatment of five major tumour sites. The infrastructure has been used successfully to support and encourage trial participation. Challenges for the future are a re-orientation towards prospective audit, widening the constituency and sense of ownership of SCTN as a resource for practising clinicians, and further increasing recruitment into clinical trials. © 1999 Cancer Research Campaign
format Text
id pubmed-2362781
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23627812009-09-10 In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model Stroner, P L Brewster, D H Dewar, J A Eremin, O Gould, A Howard, G C Kaye, S B Br J Cancer Review The Scottish Cancer Therapy Network (SCTN) was created against a background of rising concerns about perceived variation in the quality of care available to patients with cancer. SCTN has established itself as a major organization with the necessary recognition and infrastructure to provide leadership, support and impetus in the field of clinical guidelines, clinical audit and clinical trials of cancer therapy in Scotland. Since being formed in 1993, SCTN has been instrumental in the development of three evidence-based, clinical guidelines and in the completion of detailed, national, retrospective audits of the treatment of five major tumour sites. The infrastructure has been used successfully to support and encourage trial participation. Challenges for the future are a re-orientation towards prospective audit, widening the constituency and sense of ownership of SCTN as a resource for practising clinicians, and further increasing recruitment into clinical trials. © 1999 Cancer Research Campaign Nature Publishing Group 1999-04 /pmc/articles/PMC2362781/ /pubmed/10206271 http://dx.doi.org/10.1038/sj.bjc.6690262 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Stroner, P L
Brewster, D H
Dewar, J A
Eremin, O
Gould, A
Howard, G C
Kaye, S B
In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model
title In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model
title_full In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model
title_fullStr In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model
title_full_unstemmed In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model
title_short In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model
title_sort in pursuit of excellence for patients with cancer: the scottish cancer therapy network model
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362781/
https://www.ncbi.nlm.nih.gov/pubmed/10206271
http://dx.doi.org/10.1038/sj.bjc.6690262
work_keys_str_mv AT stronerpl inpursuitofexcellenceforpatientswithcancerthescottishcancertherapynetworkmodel
AT brewsterdh inpursuitofexcellenceforpatientswithcancerthescottishcancertherapynetworkmodel
AT dewarja inpursuitofexcellenceforpatientswithcancerthescottishcancertherapynetworkmodel
AT eremino inpursuitofexcellenceforpatientswithcancerthescottishcancertherapynetworkmodel
AT goulda inpursuitofexcellenceforpatientswithcancerthescottishcancertherapynetworkmodel
AT howardgc inpursuitofexcellenceforpatientswithcancerthescottishcancertherapynetworkmodel
AT kayesb inpursuitofexcellenceforpatientswithcancerthescottishcancertherapynetworkmodel